Address: Magdalen Centre The Oxford Science Park Oxford OX4 4GA,United Kingdom
Tel: +44 (0)1865 784574
Circassia is a specialty biopharmaceutical company focused on developing world-class immunotherapies. These include a new class of T-cell vaccines designed to treat a broad range of allergies, and therapies to combat autoimmune conditions such as rheumatoid arthritis and psoriasis. The Company has made rapid progress since its establishment in 2006, and several of its products are currently in mid- to late-stage development, having successfully completed a number of phase II clinical studies.
Products and services
Circassia has a broad portfolio of immuno-based therapies, with many currently progressing through clinical development. The company has completed a number of successful phase II studies and plans to advance several products into the final stage of development in the near future.